Work

5-HT2A Receptor Promoter Polymorphism, -1438G/A and Negative Symptom Response to Olanzapine in Schizophrenia

Year: 2025

Type: article

Source: Psychopharmacology Bulletin

DOI: 10.64719/pb.4188

Authors: Vicki L. Ellingrod, PharmD, BCPP, Brian C. Lund, PharmD, MS, BCPP, Paul J. Perry, PhD, BCPP, Kristy Bever-Stille, PharmD, BCPP, Frank Fleming, BSN, Timothy L. Holman, MA, and Del Miller, PharmD, MD

Institution: University of Iowa

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2413467414

FWCI: 0.632

Cites:

Cited by: 41

Related to: 10